We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 488

Food, Dietary Supplement & Cosmetics Regulatory Update, Volume III, Issue 2
  • Jones Day
  • USA
  • January 21 2016

Last week, Campbell Soup Co. became the first major company to announcethat it will label all U.S. products derived from genetically modified ("GM"


Food, Dietary Supplement & Cosmetics Regulatory Update Volume III, Issue 1
  • Jones Day
  • USA
  • January 8 2016

The Obama administration has released the updated Dietary Guidelines for Americans with a new focus on limiting sugar. The Guidelines are revised


Food, Dietary Supplement & Cosmetics Regulatory Update Volume II, Issue 22
  • Jones Day
  • European Union, USA
  • December 18 2015

On December 7, 2015, the World Trade Organization ("WTO") authorized Canada and Mexico to impose retaliatory tariffs of $780M (Canada) and $228M


Southern District of Florida Rules that 180-Day Notice of Commercial Marketing Is Mandatory When Parties "Patent Dance"
  • Jones Day
  • USA
  • December 15 2015

On December 9, 2015, United States District Court Judge James Cohn, in the Amgen v. Apotex Neulasta litigation, granted Amgen's motion for a


CMS Makes Changes to the Stark Law: Addressing Payment Reform, Reducing Burden, and Facilitating Compliance
  • Jones Day
  • USA
  • December 15 2015

On November 16, 2015, the Centers for Medicare and Medicaid Services ("CMS") published a final rule with changes to the Hospital Outpatient


Food, dietary supplement & cosmetics regulatory update Volume II, Issue 21
  • Jones Day
  • USA
  • December 3 2015

On November 13, 2015, FDA published three major Food Safety Modernization Act ("FSMA") rules. These final rules require food importers and producers


Pharmaceutical & medical device regulatory update, Vol. II, Issue 18
  • Jones Day
  • USA
  • November 20 2015

On November 17, 2015, Dr. Robert Califf testified in front of the Senate Committee on Health, Education, Labor, and Pensions as President Obama's


CMS and OIG issue final fraud and abuse waivers in connection with the Medicare Shared Savings Program
  • Jones Day
  • USA
  • November 13 2015

On October 29, 2015, the Centers for Medicare & Medicaid Services ("CMS") and the U.S. Department of Health and Human Services' Office of Inspector


Food, dietary supplement & cosmetics regulatory update Volume II, Issue 20
  • Jones Day
  • European Union, USA
  • November 13 2015

As previously published in our Jones Day Update, the United States recently closed the Trans-Pacific Partnership ("TPP") agreement with 11 other


Pharmaceutical & medical device regulatory update, Vol. II, Issue 17
  • Jones Day
  • USA
  • November 3 2015

Robert Califf, nominee for FDA Commissioner, recently coauthored an update regarding changes the agency is making to better facilitate the review of